Title:
【発明の名称】アセチルコリン受容体拮抗薬としてのエピバチジンアナログ
Document Type and Number:
Japanese Patent JP2002527506
Kind Code:
A
Abstract:
The present invention relates to novel epibatidine analogues which has formula (I) wherein R represents an alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or (hetero)arylalkyl group, said group optionally being substituted by one or more: alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, (hetero)arylalkyl, haloalkyl, amino, alkylamino amido or sulphonamido groups, R' represents hydrogen, alkyl or a nitrogen protecting group and (II) represents a single or double bond.
Inventors:
Hodgson, David Michael
Maxwell, Christopher Reginald
Maxwell, Christopher Reginald
Application Number:
JP2000577152A
Publication Date:
August 27, 2002
Filing Date:
September 22, 1999
Export Citation:
Assignee:
Isis Innovation Limited
International Classes:
C07D487/18; A61K31/439; A61K31/444; A61P25/04; A61P43/00; C07D209/52; C07D401/04; C07D471/18; (IPC1-7): C07D471/18; A61K31/439; A61K31/444; A61P25/04; A61P43/00; C07D487/18
Attorney, Agent or Firm:
Yoshio Kawaguchi (4 outside)